999 related articles for article (PubMed ID: 25660909)
1. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.
Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J
Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909
[TBL] [Abstract][Full Text] [Related]
2. The bifunctional liposomes constructed by poly(2-ethyl-oxazoline)-cholesteryl methyl carbonate: an effectual approach to enhance liposomal circulation time, pH-sensitivity and endosomal escape.
Xu H; Zhang W; Li Y; Ye FF; Yin PP; Yu X; Hu MN; Fu YS; Wang C; Shang de J
Pharm Res; 2014 Nov; 31(11):3038-50. PubMed ID: 24805279
[TBL] [Abstract][Full Text] [Related]
3. Effects of the molecular weight and molar ratio of poly(2-ethyl-2-oxazoline)-based lipid on the pH sensitivity, stability, and antitumor efficacy of liposomes.
Wen L; Huang S; Du W; Zhu C; Xu H
Drug Dev Ind Pharm; 2020 Feb; 46(2):283-295. PubMed ID: 31944130
[TBL] [Abstract][Full Text] [Related]
4. [Preparation and evaluation of doxorubicin hydrochloride liposomes modified by poly(2-ethyl-2-oxazoline)-cholesteryl methyl carbonate].
Zhang D; Li JY; Wang XC; Yue HX; Hu MN; Yu X; Xu H
Yao Xue Xue Bao; 2015 Sep; 50(9):1174-9. PubMed ID: 26757556
[TBL] [Abstract][Full Text] [Related]
5. Poly(2-ethyl-2-oxazoline)-doxorubicin conjugate-based dual endosomal pH-sensitive micelles with enhanced antitumor efficacy.
Li J; Zhou Y; Li C; Wang D; Gao Y; Zhang C; Zhao L; Li Y; Liu Y; Li X
Bioconjug Chem; 2015 Jan; 26(1):110-9. PubMed ID: 25506713
[TBL] [Abstract][Full Text] [Related]
6. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release.
Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z
Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663
[TBL] [Abstract][Full Text] [Related]
7. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity.
Zhao Y; Ren W; Zhong T; Zhang S; Huang D; Guo Y; Yao X; Wang C; Zhang WQ; Zhang X; Zhang Q
J Control Release; 2016 Jan; 222():56-66. PubMed ID: 26682502
[TBL] [Abstract][Full Text] [Related]
9. pH- and redox-responsive poly(ethylene glycol) and cholesterol-conjugated poly(amido amine)s based micelles for controlled drug delivery.
Cheng W; Kumar JN; Zhang Y; Liu Y
Macromol Biosci; 2014 Mar; 14(3):347-58. PubMed ID: 24106152
[TBL] [Abstract][Full Text] [Related]
10. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
[TBL] [Abstract][Full Text] [Related]
11. pH and reduction dual-responsive micelles based on novel polyurethanes with detachable poly(2-ethyl-2-oxazoline) shell for controlled release of doxorubicin.
Bu L; Zhang H; Xu K; Du B; Zhu C; Li Y
Drug Deliv; 2019 Dec; 26(1):300-308. PubMed ID: 30895837
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes.
Xiang G; Wu J; Lu Y; Liu Z; Lee RJ
Int J Pharm; 2008 May; 356(1-2):29-36. PubMed ID: 18258394
[TBL] [Abstract][Full Text] [Related]
13. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
[TBL] [Abstract][Full Text] [Related]
14. Facile construction of dual-bioresponsive biodegradable micelles with superior extracellular stability and activated intracellular drug release.
Chen W; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
J Control Release; 2015 Jul; 210():125-33. PubMed ID: 25987525
[TBL] [Abstract][Full Text] [Related]
15. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
16. PEG-b-PCL copolymer micelles with the ability of pH-controlled negative-to-positive charge reversal for intracellular delivery of doxorubicin.
Deng H; Liu J; Zhao X; Zhang Y; Liu J; Xu S; Deng L; Dong A; Zhang J
Biomacromolecules; 2014 Nov; 15(11):4281-92. PubMed ID: 25325531
[TBL] [Abstract][Full Text] [Related]
17. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
[TBL] [Abstract][Full Text] [Related]
19. pH-responsive cationic liposome for endosomal escape mediated drug delivery.
Rayamajhi S; Marchitto J; Nguyen TDT; Marasini R; Celia C; Aryal S
Colloids Surf B Biointerfaces; 2020 Apr; 188():110804. PubMed ID: 31972443
[TBL] [Abstract][Full Text] [Related]
20. pH and reduction dual-sensitive copolymeric micelles for intracellular doxorubicin delivery.
Chen J; Qiu X; Ouyang J; Kong J; Zhong W; Xing MM
Biomacromolecules; 2011 Oct; 12(10):3601-11. PubMed ID: 21853982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
